In reference to Does mutational analysis influence the management of differentiated thyroid cancers?

E-ISSN： 1531-4995|128|2|E84-E84

ISSN： 0023-852x

Source： THE LARYNGOSCOPE, Vol.128, Iss.2, 2018-02, pp. : E84-E84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

In response to Does mutational analysis influence the management of differentiated thyroid cancers?

THE LARYNGOSCOPE, Vol. 128, Iss. 2, 2018-02 ,pp. : E85-E85

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of differentiated thyroid cancer of the follicular epithelium

By Pacini Furio

Annals of Medicine, Vol. 44, Iss. 7, 2012-11 ,pp. : 651-655

Informa Healthcare

Access to resources Recommend Favorite

Mutational testing and its utility in thyroid cancer management: the need for something more

By Vitale Mario

Biomarkers in Medicine, Vol. 7, Iss. 4, 2013-08 ,pp. : 571-574

Future Medicine

Access to resources Recommend Favorite

Management of recurrent and persistent metastatic lymph nodes in well‐differentiated thyroid cancer: A multifactorial decision‐making guide for the thyroid cancer care collaborative

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 4, 2015-04 ,pp. : 605-614

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, Vol. 59, Iss. 3, 2015-06 ,pp. : 281-288

John Wiley & Sons Inc

Access to resources Recommend Favorite